| BDNF-induced changes in the expression of the translation machinery in hippocampal neurons: protein levels and dendritic mRNA. Manadas B., Santos A.R., Szabadfi K., Gomes J.R., Garbis S.D., Fountoulakis M., Duarte C.B.
J. Proteome Res. 8:4536-4552(2009) · Mapped (3) |
| Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Karamessinis P.M., Malamitsi-Puchner A., Boutsikou T., Makridakis M., Vougas K., Fountoulakis M., Vlahou A., Chrousos G.
Mol. Cell Proteomics 7:591-599(2008) · Mapped (3) |
| Alterations in the heart mitochondrial proteome in a desmin null heart failure model. Fountoulakis M., Soumaka E., Rapti K., Mavroidis M., Tsangaris G., Maris A., Weisleder N., Capetanaki Y.
J. Mol. Cell. Cardiol. 38:461-474(2005) · Mapped (3) |
| Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Kirchner L., Weitzdoerfer R., Hoeger H., Url A., Schmidt P., Engelmann M., Villar S.R., Fountoulakis M., Lubec G., Lubec B.
Nitric Oxide 11:316-330(2004) · Mapped (2) |
| Hypothetical proteins with putative enzyme activity in human amnion, lymphocyte, bronchial epithelial and kidney cell lines. Afjehi-Sadat L., Krapfenbauer K., Slavc I., Fountoulakis M., Lubec G.
Biochim. Biophys. Acta 1700:65-74(2004) · UniProtKB (1) |
| Expression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain. Shin J.H., Weitzdoerfer R., Fountoulakis M., Lubec G.
Neurochem. Int. 45:73-79(2004) · Mapped (7) |
| Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease. Cheon M.S., Kim S.H., Fountoulakis M., Lubec G.
J. Neural Transm. Suppl. 2003:225-234(2003) · Mapped (3) |
| Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain. Fountoulakis M., Gulesserian T., Lubec G.
J. Neural Transm. Suppl. 2003:85-93(2003) · Mapped (12) |
| Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Hengstschlager M., Rosner M., Fountoulakis M., Lubec G.
Biochem. Biophys. Res. Commun. 312:676-683(2003) · Mapped (6) |
| Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain. Myung J.K., Gulesserian T., Fountoulakis M., Lubec G.
Cell. Mol. Biol. 49:739-746(2003) · UniProtKB (1) |
| Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products. Hengstschlager M., Rosner M., Fountoulakis M., Lubec G.
Biochem. Biophys. Res. Commun. 307:737-742(2003) · Mapped (10) |
| Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Jiang L., Lindpaintner K., Li H.F., Gu N.F., Langen H., He L., Fountoulakis M.
Amino Acids 25:49-57(2003) · Mapped (2) |
| Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., Lubec G.
Brain Res. 967:152-160(2003) · Mapped (10) |
| Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain. Bernert G., Fountoulakis M., Lubec G.
Proteomics 2:1752-1757(2002) · UniProtKB (1) · Mapped (16) |
| Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome. Kim S.H., Fountoulakis M., Cairns N.J., Lubec G.
Biochem. Biophys. Res. Commun. 296:970-975(2002) · Mapped (3) |
| Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease. Kim S.H., Krapfenbauer K., Cheon M.S., Fountoulakis M., Cairns N.J., Lubec G.
Neurosci. Lett. 321:169-172(2002) · Mapped (2) |
| Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21), AND MASS SPECTROMETRY. Peyrl A., Weitzdoerfer R., Gulesserian T., Fountoulakis M., Lubec G.
Electrophoresis 23:152-157(2002) · UniProtKB (1) · Mapped (12) |
| Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. Weitzdoerfer R., Fountoulakis M., Lubec G.
J. Neural Transm. Suppl. 2001:95-107(2001) · Mapped (13) |
| Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. Gulesserian T., Engidawork E., Fountoulakis M., Lubec G.
J. Neural Transm. Suppl. 2001:71-84(2001) · Mapped (2) |
| Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down syndrome brain. Weitzdoerfer R., Stolzlechner D., Dierssen M., Ferreres J., Fountoulakis M., Lubec G.
J. Neural Transm. Suppl. 2001:347-359(2001) · Mapped (6) |
| Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1. Yoo B.C., Fountoulakis M., Dierssen M., Lubec G.
J. Neural Transm. Suppl. 2001:321-334(2001) · Mapped (2) |
| Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains. Kim S.H., Dierssen M., Ferreres J.C., Fountoulakis M., Lubec G.
J. Neural Transm. Suppl. 2001:273-280(2001) · Mapped (2) |
| Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. Kim S.H., Fountoulakis M., Cairns N., Lubec G.
J. Neural Transm. Suppl. 2001:223-235(2001) · Mapped (8) |
| Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome. Engidawork E., Juranville J.F., Fountoulakis M., Dierssen M., Lubec G.
J. Neural Transm. 61:117-130(2001) · UniProtKB (1) · Mapped (3) |
| Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains. Kim S.H., Fountoulakis M., Dierssen M., Lubec G.
J. Neural Transm. Suppl. 2001:109-116(2001) · Mapped (5) |
